Rainer Lutz

14PUBLICATIONS
22CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPeriodonticsOral implantology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 26, 2026
Oral Side Effects of the Most Commonly Prescribed Drugs in Germany.

Frank Halling, Rainer Lutz, Axel Meisgeier

|Sep 27, 2024
Comparative Analysis of Inhibitory and Activating Immune Checkpoints PD-1, PD-L1, CD28, and CD86 in Non-Melanoma Skin Cancer.

Linus Winter, Jutta Ries, Christoph Vogl

|Jun 27, 2024
The Immune Checkpoint BTLA in Oral Cancer: Expression Analysis and Its Correlation to Other Immune Modulators.

Jutta Ries, Leah Trumet, Alina Hahn

|Mar 13, 2024
Neoadjuvant Radiochemotherapy Alters the Immune and Metabolic Microenvironment in Oral Cancer-Analyses of CD68, CD163, TGF-β1, GLUT-1 and HIF-1α Expressions.

Manuel Weber, Jutta Ries, Kristina Braun

|Aug 12, 2023
Postoperative Changes in Systemic Immune Tolerance Following Major Oncologic versus Minor Maxillofacial Surgery.

Leah Trumet, Jutta Ries, Philip Sobl

|May 13, 2023
A Treatment Approach for Carotid Blowout Syndrome and Soft Tissue Reconstruction after Radiotherapy in Patients with Oral Cancer: A Report of 2 Cases.

Tobias Moest, Marco Rainer Kesting, Maximilian Rohde

Pageof 3

Frequent Collaborators

7 joint publications

Jutta Ries

7 joint publications

Manuel Weber

2 joint publications

Tobias Moest

2 joint publications

Marco Kesting